Home » Topics » Regulatory » EMA

EMA
RSS

CHMP recommends variations to marketing authorization of Cancidas

Sep. 30, 2008

CHMP recommends marketing authorization for Azarga in open-angle glaucoma

Sep. 30, 2008

GSK withdraws European MAA for Quintanrix vaccine

Sep. 3, 2008

EMEA presents an update on reports of PML in MS patients treated with Tysabri

Aug. 14, 2008

CHMP recommends marketing authorization for GSK's prepandemic influenza vaccine

July 30, 2008

Anticoagulant Xarelto recommended for approval in E.U.; NDA submitted in U.S.

July 30, 2008

CHMP recommends refusal of Santhera's MAA for Sovrima in Friedreich's ataxia

July 30, 2008

CHMP adopts negative opinion for Howmedica's Opgenra

July 4, 2008

EMEA recommends that product information for Pfizer's Exubera include data on lung cancer

June 19, 2008

Novartis withdraws MAA for pre-pandemic vaccine Aflunov

June 18, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...